Pharmaceutical Supply Chain (ePub)

Name: Pharmaceutical Supply Chain
Brand: Taylor & Francis
SKU: 152834214
Price: 44.49 EUR
Availability: OnlineOnly

Drug Quality and Security Act (Sprache: Englisch)

Autor: Fred A. Kuglin

Schreiben Sie einen Kommentar zu "Pharmaceutical Supply Chain".

Pharmaceutical Supply Chain, Fred A. Kuglin

Merken

Mehr zum Inhalt Autorenporträt Video

Leider schon ausverkauft

Bestellnummer: 152834214

eBook (ePub) 44.49 €

Download bestellen

Verschenken

22 DeutschlandCard Punkte sammeln

Lastschrift, Kreditkarte, Paypal, Rechnung
Kostenloser tolino webreader

Produktdetails

Produktbeschreibung
Autorenporträt
eBook Hilfe
Biblio. Angaben / Produktdetails

Produktinformationen zu „Pharmaceutical Supply Chain (ePub)“

Error-proofing in the production process of pharmaceuticals isn't just a matter of good business, it has life-and-death implications for consumers. The 2013 Drug Quality and Security Act introduces more stringent compliance factors towards this common goal, in large part requiring new mandates on tracking and tracing chain of custody in the supply chain. This book comprehensively overviews the new mandate and its implications, including implementation strategies for track-and-trace programs along with presenting a fuller understanding of the mechanics of intergovernmental policies and oversights.

Autoren-Porträt von Fred A. Kuglin

Karl F. Kuglin is a professional services consultant with Ernst & Young LLP in the EY Life Sciences industry group. He helps pharmaceutical companies to adapt and lead change to the industry, including emerging science, new products and services, shifting demographics, evolving regulations (such as the Drug Quality and Security Act), transforming business models, and increased stakeholder expectations.

Kuglin has operational leadership experience with one of the leading return logistics companies in the pharmaceutical industry. This experience includes an in-depth knowledge of the regulations governing pharmaceutical drugs (including controlled substances). He led a team responsible for the receipt, processing, return to manufacturer, and destruction of returned pharmaceutical drugs, and the accuracy of the application for credit allowances to pharmaceutical manufacturers. His contribution to Chapter 7,When Things Go Bump in the Night: Reverse Logistics, was invaluable. Kuglin is a graduate of Indiana University with a major in business administration.